Z-0252-2020 Class II Terminated
FDA device recall Z-0252-2020 was initiated by Becton Dickinson & Company on Mar 7, 2019 and is designated Class II. Reason for recall: BD PAS received customer complaints indicating the absence of the bevel on the non-patient needle end of the product, causing blood leakage. The recall status is terminated (terminated Feb 11, 2022). Affected quantity: 2,624,160 (2,169,703 US; 454,457 OUS).
Recall details
- Product Type
- Devices
- Report Date
- Nov 6, 2019
- Initiation Date
- Mar 7, 2019
- Termination Date
- Feb 11, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,624,160 (2,169,703 US; 454,457 OUS)
Product description
BD Vacutainer Eclipse Blood Collection Needles 22Gx1.25, cat. no. 368608
Reason for recall
BD PAS received customer complaints indicating the absence of the bevel on the non-patient needle end of the product, causing blood leakage.
Distribution pattern
Distributed to accounts in AR, CT, FL, IL, IN, MI, MO, MS, NY, OH, TN, TX, and VA. Foreign distribution to Canada, Brazil, India, Mexico, Singapore, and Taiwan.
Code information
Lot 8207894 ***UPDATED 7/11/19*** Lots 9025826 and 8354527 ***UPDATED 12/10/19*** Lot 9010765
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0252-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026